Third-Generation Anti–Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis

Di Matteo A, Mankia K, Duquenne L, Mahler M, Corscadden D, Mbara K, Garcia-Montoya L, Nam JL, Emery P. Third-Generation Anti–Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis. Arthritis Rheumatol. 2020 Nov;72(11):1820-1828.